BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38167862)

  • 1. FOXP3
    Liu X; Zhang W; Han Y; Cheng H; Liu Q; Ke S; Zhu F; Lu Y; Dai X; Wang C; Huang G; Su B; Zou Q; Li H; Zhao W; Xiao L; Lu L; Tong X; Pan F; Li H; Li B
    Nat Commun; 2024 Jan; 15(1):122. PubMed ID: 38167862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoted Generation of T Helper 1-Like Regulatory T Cells After Transient Middle Cerebral Artery Occlusion in Type-2 Diabetic Mice.
    Jian L; Hu Y; Gao M; Shu L
    Immunol Invest; 2023 Nov; 52(4):482-498. PubMed ID: 37076315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-27 confers a protumorigenic activity of regulatory T cells via CD39.
    Park YJ; Ryu H; Choi G; Kim BS; Hwang ES; Kim HS; Chung Y
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3106-3111. PubMed ID: 30718407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caerulomycin A enhances transforming growth factor-β (TGF-β)-Smad3 protein signaling by suppressing interferon-γ (IFN-γ)-signal transducer and activator of transcription 1 (STAT1) protein signaling to expand regulatory T cells (Tregs).
    Gurram RK; Kujur W; Maurya SK; Agrewala JN
    J Biol Chem; 2014 Jun; 289(25):17515-28. PubMed ID: 24811173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression.
    Kurebayashi Y; Olkowski CP; Lane KC; Vasalatiy OV; Xu BC; Okada R; Furusawa A; Choyke PL; Kobayashi H; Sato N
    Cancer Res; 2021 Jun; 81(11):3092-3104. PubMed ID: 33574087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-{gamma} and IL-17A production.
    Takahashi R; Nishimoto S; Muto G; Sekiya T; Tamiya T; Kimura A; Morita R; Asakawa M; Chinen T; Yoshimura A
    J Exp Med; 2011 Sep; 208(10):2055-67. PubMed ID: 21893603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD39
    Gu J; Ni X; Pan X; Lu H; Lu Y; Zhao J; Guo Zheng S; Hippen KL; Wang X; Lu L
    Cell Mol Immunol; 2017 Jun; 14(6):521-528. PubMed ID: 27374793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.
    Cohen AD; Schaer DA; Liu C; Li Y; Hirschhorn-Cymmerman D; Kim SC; Diab A; Rizzuto G; Duan F; Perales MA; Merghoub T; Houghton AN; Wolchok JD
    PLoS One; 2010 May; 5(5):e10436. PubMed ID: 20454651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer.
    Revenko A; Carnevalli LS; Sinclair C; Johnson B; Peter A; Taylor M; Hettrick L; Chapman M; Klein S; Solanki A; Gattis D; Watt A; Hughes AM; Magiera L; Kar G; Ireland L; Mele DA; Sah V; Singh M; Walton J; Mairesse M; King M; Edbrooke M; Lyne P; Barry ST; Fawell S; Goldberg FW; MacLeod AR
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35387780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AKT isoforms modulate Th1-like Treg generation and function in human autoimmune disease.
    Kitz A; de Marcken M; Gautron AS; Mitrovic M; Hafler DA; Dominguez-Villar M
    EMBO Rep; 2016 Aug; 17(8):1169-83. PubMed ID: 27312110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Providence of the CD25
    Chakraborty S; Bhattacharjee P; Panda AK; Kajal K; Bose S; Sa G
    Immunol Cell Biol; 2018 Nov; 96(10):1035-1048. PubMed ID: 29768737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remodeling of the tumor microenvironment via disrupting Blimp1
    Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
    Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-γ Drives T
    Overacre-Delgoffe AE; Chikina M; Dadey RE; Yano H; Brunazzi EA; Shayan G; Horne W; Moskovitz JM; Kolls JK; Sander C; Shuai Y; Normolle DP; Kirkwood JM; Ferris RL; Delgoffe GM; Bruno TC; Workman CJ; Vignali DAA
    Cell; 2017 Jun; 169(6):1130-1141.e11. PubMed ID: 28552348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m
    Wang L; Hui H; Agrawal K; Kang Y; Li N; Tang R; Yuan J; Rana TM
    EMBO J; 2020 Oct; 39(20):e104514. PubMed ID: 32964498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma triggered STAT1-PKB/AKT signalling pathway influences the function of alloantigen reactive regulatory T cells.
    Wei B; Baker S; Wieckiewicz J; Wood KJ
    Am J Transplant; 2010 Jan; 10(1):69-80. PubMed ID: 19889125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome.
    Uzel G; Sampaio EP; Lawrence MG; Hsu AP; Hackett M; Dorsey MJ; Noel RJ; Verbsky JW; Freeman AF; Janssen E; Bonilla FA; Pechacek J; Chandrasekaran P; Browne SK; Agharahimi A; Gharib AM; Mannurita SC; Yim JJ; Gambineri E; Torgerson T; Tran DQ; Milner JD; Holland SM
    J Allergy Clin Immunol; 2013 Jun; 131(6):1611-23. PubMed ID: 23534974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of IFITM1 and IFITM3 gene deletion on IFNγ stimulated protein synthesis.
    Gómez-Herranz M; Nekulova M; Faktor J; Hernychova L; Kote S; Sinclair EH; Nenutil R; Vojtesek B; Ball KL; Hupp TR
    Cell Signal; 2019 Aug; 60():39-56. PubMed ID: 30951861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors.
    Colbeck EJ; Hindley JP; Smart K; Jones E; Bloom A; Bridgeman H; McPherson RC; Turner DG; Ladell K; Price DA; O'Connor RA; Anderton SM; Godkin AJ; Gallimore AM
    Oncotarget; 2015 Sep; 6(28):24649-59. PubMed ID: 26433463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
    Bhaumik S; Mickael ME; Moran M; Spell M; Basu R
    J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOCS1 Is a Key Molecule That Prevents Regulatory T Cell Plasticity under Inflammatory Conditions.
    Takahashi R; Nakatsukasa H; Shiozawa S; Yoshimura A
    J Immunol; 2017 Jul; 199(1):149-158. PubMed ID: 28550203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.